SOPHiA GENETICS (SOPH) has released an update.
SOPHiA GENETICS is advancing global healthcare through its AI platform, SOPHiA DDM, which fosters scientific collaboration and broadens access to data-driven medicine, serving over 770 healthcare institutions in 68 countries. The company prioritizes the protection of patient data, adhering to strict data protection laws and implementing robust security measures, while also focusing on employee empowerment and diversity. With a vision of providing equal world-class care to patients, SOPHiA GENETICS emphasizes innovation, access, and ethical integrity in its ongoing ESG journey.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
